Guido Marcucci, MD | Authors

December 26, 2016

This look ahead at hematologic malignancies in 2017 focuses on new agents being studied for the treatment of acute leukemias, myelodysplastic syndromes, and chronic lymphocytic leukemia.

December 15, 2016

In this article we discuss the challenges and new advances in adult ALL, as well as our approach to the treatment of these patients.

April 16, 2016

We review here the state of the art of diagnosis and treatment of AML and provide insights into the emerging novel biomarkers and therapeutic agents that are anticipated to be useful for the implementation of personalized medicine in AML.